The Digestive Diseases Research Core Center brings together a multidisciplinary group of independently funded principal investigators and professional supporting personnel from the Departments of Medicine, Pathology, Diagnostic Radiology, Laboratory Medicine, Physiology, Human Genetics and Cell Biology at Yale School of Medicine, in order to further the study of liver structure, function and disease at this institution. The Center focuses on 5 major themes: (1) Mechanisms of hepatic transport and bile secretion; (2) Hepatic metabolic functions including bilirubin metabolism, effects of ethanol, and genetic aspects of mitochondrial enzyme function; (3) Hepatic fibrogenesis; (4) Splanchnic hemodynamics; and (5) Human liver transplantation. The research activities of the Center are broad, and range from fundamental studies of the biology of the hepatocyte to the immediate relevancy of the evaluation of the human liver transplant. The principle goals of the Center have been to: (1) stimulate multidisciplinary interactions; (2) efficiently organize time consuming or costly techniques and procedures in Core Facilities for multiple use; (3) stimulate basic scientists to become involved in one or more of the Center's areas of research interest; (4) capitalize on important new research opportunities through pilot feasibility projects; and (5) create an institutional environment that will greatly amplify progress in answering problems in this important area of Digestive Disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK034989-03
Application #
3102080
Study Section
(SRC)
Project Start
1984-09-30
Project End
1989-08-31
Budget Start
1986-09-01
Budget End
1987-08-31
Support Year
3
Fiscal Year
1986
Total Cost
Indirect Cost
Name
Yale University
Department
Type
Schools of Medicine
DUNS #
082359691
City
New Haven
State
CT
Country
United States
Zip Code
06520
Brivio, Simone; Cadamuro, Massimiliano; Fabris, Luca et al. (2018) Molecular Mechanisms Driving Cholangiocarcinoma Invasiveness: An Overview. Gene Expr 18:31-50
Cox, Carly S; McKay, Sharen E; Holmbeck, Marissa A et al. (2018) Mitohormesis in Mice via Sustained Basal Activation of Mitochondrial and Antioxidant Signaling. Cell Metab 28:776-786.e5
Madiraju, Anila K; Qiu, Yang; Perry, Rachel J et al. (2018) Metformin inhibits gluconeogenesis via a redox-dependent mechanism in vivo. Nat Med 24:1384-1394
Schmitz, Corinna; Noels, Heidi; El Bounkari, Omar et al. (2018) Mif-deficiency favors an atheroprotective autoantibody phenotype in atherosclerosis. FASEB J 32:4428-4443
Pan, Qiong; Zhang, Xiaoxun; Zhang, Liangjun et al. (2018) Solute Carrier Organic Anion Transporter Family Member 3A1 Is a Bile Acid Efflux Transporter in Cholestasis. Gastroenterology 155:1578-1592.e16
Jakab, Sofia Simona; Garcia-Tsao, Guadalupe (2018) Screening and Surveillance of Varices in Patients With Cirrhosis. Clin Gastroenterol Hepatol :
Fiorotto, Romina; Amenduni, Mariangela; Mariotti, Valeria et al. (2018) Src kinase inhibition reduces inflammatory and cytoskeletal changes in ?F508 human cholangiocytes and improves cystic fibrosis transmembrane conductance regulator correctors efficacy. Hepatology 67:972-988
Sari, Sinan; Dalgic, Buket; Muehlenbachs, Atis et al. (2018) Prototheca zopfii Colitis in Inherited CARD9 Deficiency. J Infect Dis 218:485-489
Yu, Dongke; Cai, Shi-Ying; Mennone, Albert et al. (2018) Cenicriviroc, a cytokine receptor antagonist, potentiates all-trans retinoic acid in reducing liver injury in cholestatic rodents. Liver Int 38:1128-1138
Garcia-Tsao, Guadalupe (2018) Regression of HCV cirrhosis: Time will tell. Hepatology 67:1651-1653

Showing the most recent 10 out of 763 publications